Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean sodium citrate and anhydrous catus acid?
Displaying drugs 15276 - 15300 of 15527 in total

4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE

Experimental

1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE

Experimental

3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA

Experimental

2,6-dibromo-4-phenoxyphenol

Experimental

[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE

Experimental

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

Experimental

[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE

Experimental

MK-4965

MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental

N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide

Experimental

5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole

5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole targets the protein genome polyprotein.
Experimental

Diclazuril

Diclazuril is a coccidiostat.
Investigational
Vet approved

Ponazuril

Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
Vet approved

Henagliflozin

Henagliflozin has been used in trials studying the treatment of Type 2 Diabetes.
Investigational

Chlorproguanil

Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
Investigational

Clofoctol

Experimental

Tolpropamine

Experimental

Suloctidil

Experimental

Eprozinol

Experimental

Etybenzatropine

Experimental

Tiocarlide

Experimental

Quifenadine

Experimental

Penfluridol

Experimental

AGI-1096

AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to address the accelerated inflammation of grafted blood vessels, known as transplant arteritis, common in chronic organ transplant rejection.
Investigational
Matched Description: … AGI-1096 is a novel oral antioxidant and selective anti-inflammatory agent that is being developed to …

Bleximenib

Bleximenib is under investigation in clinical trials NCT04811560 (A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia) and NCT05453903 (A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies)
Investigational
Matched Description: … in clinical trials NCT04811560 (A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia) and …

MRX-I

MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Displaying drugs 15276 - 15300 of 15527 in total